Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

Betty S. ChanClinical Toxicology Unit & Emergency Department, Prince of Wales Hospital, Sydney, NSW, Australia;New South Wales Poisons Information Centre, Sydney, AustraliaCorrespondence[email protected]

Angela ChiewClinical Toxicology Unit & Emergency Department, Prince of Wales Hospital, Sydney, NSW, Australia;New South Wales Poisons Information Centre, Sydney, Australia

Geoffrey K. IsbisterNew South Wales Poisons Information Centre, Sydney, Australia;Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Australia

Margaret O’LearyClinical Toxicology Research Group, University of Newcastle, Newcastle, Australia;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Australia

Nicholas A. BuckleyNew South Wales Poisons Information Centre, Sydney, Australia;Clinical Pharmacology, University of Sydney, Sydney, Australia

References

Abad-Santos F, Carcas AJ, Ibanez C, Frias J. Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Ther Drug Monit. 2000;22:163–168.
PubMed Web of Science ®Google Scholar
Chan BS, Isbister GK, O'Leary M, Chiew A, Buckley NA. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Clin Toxicol (Phila). 2016;54:488–494.
PubMed Web of Science ®Google Scholar
Eyer F, Steimer W, Muller C, Zilker T. Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study. Am J Crit Care. 2010;19:391–387.
PubMed Web of Science ®Google Scholar
Cano NJ, Sabouraud AE, Debray M, Scherrmann JM. Dose-dependent reversal of digoxin-inhibited activity of an in vitro Na + K+ATPase model by digoxin-specific antibody. Toxicol Lett. 1996;85:107–111.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date